Alenka Jejcic

Artiklar

Article: RETROVIROLOGY. 2010;7:20
GPG-NH₂ acts via the metabolite αHGA to target HIV-1 Env to the ER-associated protein degradation pathway
Jejcic A; Hoglund S; Vahlne A
Article: JOURNAL OF VIROLOGY. 2009;83(19):10075-10084
Small Molecule Targets Env for Endoplasmic Reticulum-Associated Protein Degradation and Inhibits Human Immunodeficiency Virus Type 1 Propagation
Jejcic A; Daniels R; Goobar-Larsson L; Hebert DN; Vahlne A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2005;49(1):40-44
Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide
Andersson E; Horal P; Jejcic A; Höglund S; Balzarini J; Vahlne A; Svennerholm B
Article: JOURNAL OF HUMAN VIROLOGY. 2001;4(1):8-15
The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication
Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
Article: JOURNAL OF GENERAL VIROLOGY. 1998;79:2929-2937
Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus
Tecle T; Johansson B; Jejcic A; Forsgren M; Orvell C

Anknuten till Forskning, Neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2025-2026
Laboratorieingenjör, Neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2022-2025

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2011
Medicine Magisterexamen, Karolinska Institutet, 2000
Medicine Kandidatexamen, Karolinska Institutet, 1998